Travel agency JTB Corp. has started selling its communication system, dubbed Kotozna In-room, that allows guests to chat with the staff of lodging facilities using their smartphones to reduce coronavirus exposure.
The system, which was jointly developed with Tokyo-based multilingual chat service provider Kotozna Inc., can translate 109 languages, allowing communication with foreign guests in their mother tongues.
Most lodging facilities provide tablets at guest rooms for communication, but the new system can alleviate the fear of infections by allowing guests to use their smartphones.
Once guests scan a QR code via their smartphones, they can chat with lodging staff from anywhere in the facilities without downloading an application.
The system can also help streamline operations at lodging facilities with standard questions being answered by chatbots, enabling staff to do other work.
JTB charges a minimum of $2,400 per lodging facility, with an additional monthly fee per room.


Instagram Outage Disrupts Thousands of U.S. Users
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



